These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32576337)

  • 1. Public-Private-People Partnerships (4P) for Improving the Response to COVID-19 in Iran.
    Seddighi H; Seddighi S; Salmani I; Sharifi Sedeh M
    Disaster Med Public Health Prep; 2021 Feb; 15(1):e44-e49. PubMed ID: 32576337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19: Opportunity to Re-Imagine Our Response to a National Medical Crisis.
    Remick KN; Carr BG; Elster E
    J Am Coll Surg; 2021 May; 232(5):793-796. PubMed ID: 33592250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moving toward a common goal via cross-sector collaboration: lessons learned from SARS to COVID-19 in Singapore.
    Kim S; Goh Y; Kang JHB
    Global Health; 2022 Sep; 18(1):82. PubMed ID: 36131348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of the Private Sector in the COVID-19 Pandemic: Experiences From Four Health Systems.
    Wallace LJ; Agyepong I; Baral S; Barua D; Das M; Huque R; Joshi D; Mbachu C; Naznin B; Nonvignon J; Ofosu A; Onwujekwe O; Sharma S; Quayyum Z; Ensor T; Elsey H
    Front Public Health; 2022; 10():878225. PubMed ID: 35712320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The untimely demise of the TB Free block model in the wake of coronavirus disease 2019 in India.
    Datta B; Jaiswal A; Goyal P; Prakash A; Tripathy JP; Trehan N
    Trans R Soc Trop Med Hyg; 2020 Nov; 114(11):789-791. PubMed ID: 32797204
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of the COVID-19 Pandemic in the Republic of Korea from the Perspective of Governance and Public-Private Partnership.
    Kim W; Jung TY; Roth S; Um W; Kim C
    Yonsei Med J; 2021 Sep; 62(9):777-791. PubMed ID: 34427063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. India's crusade against COVID-19.
    Madkaikar M; Gupta N; Yadav RM; Bargir UA
    Nat Immunol; 2021 Mar; 22(3):258-259. PubMed ID: 33627877
    [No Abstract]   [Full Text] [Related]  

  • 8. Steering the Private Sector in COVID-19 Diagnostic Test Kit Development in South Korea.
    Lee S
    Front Public Health; 2020; 8():563525. PubMed ID: 33282810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maturing of public-private-people partnership (4P): Lessons from 4P for triple disaster and subsequently COVID-19 pandemic in Fukushima.
    Kobashi Y; Shimazu Y; Sonoda Y; Saito H; Yoshida M; Tsubokura M
    J Glob Health; 2022 Jul; 12():03028. PubMed ID: 35674274
    [No Abstract]   [Full Text] [Related]  

  • 10. Public-private partnership to rapidly strengthen and scale COVID-19 response in Western Kenya.
    van Duijn S; Barsosio HC; Omollo M; Milimo E; Akoth I; Aroka R; de Sanctis T; K'Oloo A; June MJ; Houben N; Wilming C; Otieno K; Kariuki S; Onsongo S; Odhiambo A; Ganda G; Rinke de Wit TF
    Front Public Health; 2022; 10():837215. PubMed ID: 36733283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Contextual Factors in Private Sector Engagement: A Case Study of Private Sector Contribution to COVID-19 Mitigation in Nigeria.
    Okeke C; Eigbiremolen GO; Uzochukwu B; Mbachu C; Onwujekwe O
    Front Public Health; 2022; 10():915330. PubMed ID: 35801254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biopharma innovation trends during COVID-19 and beyond: an evidence from global partnerships and fundraising activities, 2011-2022.
    Yu TH; Mei YY; Tseng YJ
    Global Health; 2023 Aug; 19(1):57. PubMed ID: 37580752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Private sector engagement in the COVID-19 response: experiences and lessons from the Democratic Republic of Congo, Nigeria, Senegal and Uganda.
    Kabwama SN; Kiwanuka SN; Mapatano MA; Fawole OI; Seck I; Namale A; Ndejjo R; Kizito S; Monje F; Bosonkie M; Egbende L; Bello S; Bamgboye EA; Dairo MD; Adebowale AS; Salawu MM; Afolabi RF; Diallo I; Leye MMM; Ndiaye Y; Fall M; Bassoum O; Alfvén T; Sambisa W; Wanyenze RK
    Global Health; 2022 Jun; 18(1):60. PubMed ID: 35705961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A model for public-private partnership during the COVID-19 pandemic: Lessons from Biolab and public laboratories working in the Hashemite Kingdom of Jordan.
    Abu-Dayyeh I; Naber Z; Meredith LW; Alsawalha L; Nassar D; Sumrain L; Ghunaim M; Hasan T; Abdelnour A
    Influenza Other Respir Viruses; 2023; 17(10):e13209. PubMed ID: 37885370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of Covid-19 pandemic on healthcare utilization in public vs private centers in Iran: a multiple group interrupted time-series analysis.
    Rezaei Z; Lotfi F; Bayati M; Kavosi Z
    BMC Health Serv Res; 2023 Aug; 23(1):822. PubMed ID: 37528374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Micronesians Building Healthier Communities During the COVID-19 Pandemic.
    Shek DM; Delafield R; Viernes JP; Pangelinan J; Sound-Kikku I; Paul J; Day TT; Asher SS
    Hawaii J Health Soc Welf; 2021 Oct; 80(10 Suppl 2):30-35. PubMed ID: 34704066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analyzing Financial Efficiency of Public-Private Partnerships Hospitals in Taiwan.
    Gao MZ; Chou YH; Chang YZ; Pai JY; Li YH; Lai YW; Yu NC
    Asia Pac J Public Health; 2023 Nov; 35(8):471-478. PubMed ID: 37837358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. University public-private partnerships for addressing student emergency needs: A literature review.
    Iman S; 'Gurt' Ge Y
    J Emerg Manag; 2021; 19(2):209-219. PubMed ID: 33954969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A strategy to guarantee oncological surgical care during the COVID-19: the public and private healthcare partnership.
    Giordano A; Forasassi L; Galli S
    Minerva Surg; 2021 Apr; 76(2):195-196. PubMed ID: 33179467
    [No Abstract]   [Full Text] [Related]  

  • 20. A public-private partnership model for COVID-19 diagnostics.
    Krijger PHL; Hoek TA; Boersma S; Donders LIPM; Broeders MMC; Pieterse M; Toonen PW; Logister I; Verhagen BMP; Verstegen MJAM; van Ravesteyn TW; Roymans RJTM; Mattiroli F; Vandesompele J; Nijhuis M; Meijer S; van Weert A; Dekker E; Dom FJ; Ruijtenbeek R; van der Velden LBJ; van de Bovenkamp JHB; Bosch M; de Laat W; Tanenbaum ME
    Nat Biotechnol; 2021 Oct; 39(10):1182-1184. PubMed ID: 34584248
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.